In addition, the increase in PD-L1 expression and decrease in the phosphorylation of LDHA suggest that, if similar changes occur in vivo, sunitinib resistance may affect the ccRCC tumor microenvironment by becoming more immunosuppressive and less glycolytic. This evidence concerns the gene LDHA and nonpapillary renal cell carcinoma.